Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors
Clinical trial NCT04789954 · COMPLETED
Trial details
- NCT number
- NCT04789954
- Sponsor
- AryoGen Pharmed Co.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2021-08-13
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.